Previous close | 4.7800 |
Open | 4.7700 |
Bid | 4.6400 x 900 |
Ask | 4.6900 x 200 |
Day's range | 4.6000 - 4.9900 |
52-week range | 1.5000 - 5.3900 |
Volume | |
Avg. volume | 2,281,482 |
Market cap | 3.264B |
Beta (5Y monthly) | -1.13 |
PE ratio (TTM) | 12.24 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript May 1, 2024 Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06. SMMT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies […]
Explore key takeaways from Summit Therapeutics' Q1 2024 earnings, including robust financial positioning and pivotal clinical advancements.
Q1 2024 Summit Therapeutics Inc Earnings Call